Search: sanofi

Sanofi-Genzyme Update – Tender Due Tomorrow!

April 6, 2011

As I’ve posted about before, Sanofi and Genzyme are merging.  This deal has taken awhile, and is structured as a tender offer.  It’s for $74 per share in cash, but also comes with a contingent value right that will be valuable if certain Genzyme drugs make it to market.  Interesting deal. Shareholders wishing to tender […]

Share
Read the full article →

Sanofi-Genzyme: $125 Million in Investment Bankers’ Fees

February 20, 2011

I’ve written a little about the Sanofi-Genzyme deal.  And, recently, had a post about investment bankers’ fees.   Those posts have remarkable synergy, considering Sanofi and Genzyme are paying a whopping $125,000,000 to their bankers.

Share
Read the full article →

Sanofi-Genzyme Update

February 16, 2011

As I noted here and here, Sanofi and Genzyme are still a-courtin’.  According to the NY Times Dealbook, today is the day the deal is announced.  I’ll write more about any interesting details.

Share
Read the full article →

Sanofi/Genzyme Close to a Deal

February 6, 2011

According to Bloomberg, the Sanofi/Genzyme deal is close.  Deals are usually announced on Monday mornings.  I wonder if we will hear something tomorrow. . .

Share
Read the full article →

Sanofi Upping its Bid for Genzyme?

January 15, 2011

Via the NY Times Dealbook Sanofi-Aventis (NYSE: ADR) may be raising its bid for Genzyme (GENZ) $7 per share.  This would result in a roughly $1.8 billion offer increase (outstanding shares x price).

Share
Read the full article →